What is the recommended dosing of Bactrim (trimethoprim-sulfamethoxazole) for an uncomplicated urinary tract infection (UTI)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 15, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bactrim Dosing for Uncomplicated UTI

Primary Recommendation

For uncomplicated UTI in women, prescribe Bactrim DS (160 mg trimethoprim/800 mg sulfamethoxazole) one tablet twice daily for 3 days. 1

Dosing by Patient Population

Women with Uncomplicated Cystitis

  • Standard dose: Bactrim DS (160/800 mg) twice daily for 3 days 1
  • This short-course regimen achieves 90-100% clinical cure rates when the pathogen is susceptible 1
  • Bacterial eradication rates are similarly excellent at 91-100% 1

Men with UTI

  • Extended duration required: Bactrim DS (160/800 mg) twice daily for 7 days 1
  • Men require longer treatment courses than women due to anatomical differences and higher risk of complicated infection 1

Complicated UTI or Pyelonephritis

  • Bactrim DS twice daily for 14 days if susceptibility is confirmed 1
  • The FDA label indicates 10-14 days for standard UTI treatment 2

Critical Prescribing Restrictions

Do not use Bactrim empirically if local E. coli resistance exceeds 20% 1

When to Avoid Bactrim:

  • Local resistance data shows >20% E. coli resistance to trimethoprim-sulfamethoxazole 1
  • Patient used Bactrim in the preceding 3-6 months 1
  • Recent travel outside the United States within 3-6 months 1
  • Last trimester of pregnancy 1

Resistance Impact on Efficacy:

  • When organisms are susceptible: 84-100% cure rate 1
  • When organisms are resistant: Only 41-54% cure rate 1
  • This dramatic drop in efficacy makes resistance screening essential 1

Alternative First-Line Agents

If Bactrim cannot be used due to resistance or contraindications:

  • Nitrofurantoin monohydrate/macrocrystals: 100 mg twice daily for 5 days (90-93% clinical cure rate) 3
  • Fosfomycin trometamol: 3 g single dose 1
  • Pivmecillinam: 400 mg twice daily for 5 days (where available) 1

These alternatives maintain resistance rates generally below 10% across most regions 1

Important Clinical Caveats

Antibiogram Interpretation:

  • Hospital antibiograms often overestimate community resistance rates 1
  • Use local outpatient surveillance data when available for more accurate empiric therapy guidance 1

Duration Considerations:

  • Each additional day of treatment beyond recommended duration carries a 5% increased risk of antibiotic-associated adverse events without additional benefit 1
  • The 3-day regimen for women has equivalent efficacy to longer courses with fewer side effects 1

Common Side Effects:

  • Rash and urticaria 1
  • Nausea and vomiting 1
  • Hematologic abnormalities 1

Renal Dosing Adjustment:

  • Creatinine clearance 15-30 mL/min: Use half the usual regimen 2
  • Creatinine clearance <15 mL/min: Use not recommended 2

Pediatric Dosing (≥2 months of age)

  • 40 mg/kg sulfamethoxazole and 8 mg/kg trimethoprim per 24 hours, divided into two doses every 12 hours for 10 days 2
  • Not recommended for children less than 2 months of age 2

References

Guideline

Uncomplicated Urinary Tract Infection Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Nitrofurantoin Dosing for Uncomplicated UTI

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.